Biogen Inc. ( BIIB) - Stock Earnings
BIIB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 28, 2026, midnight | — / — | — | — / — | — |
BIIB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -48.4 million USD | 2.3 billion USD |
| 2026Q1 | 319.5 million USD | 2.5 billion USD |
| 2026Q2 | 97.5 million USD | 2.7 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BIIB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.2 billion USD | 9.8 billion USD |
| 2024 | 1.6 billion USD | 9.7 billion USD |
| 2025 | 1.3 billion USD | 9.8 billion USD |
| 2026 Est. | — | — |
BIIB
Price: $225.71
Earnings Per Share: 5.63 USD
P/E Ratio: 37.02
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 789100
Ebitda: 1.6 billionMarket Capitalization: 32.9 billion